Notably, CD103N and CD103P cells from non-tumor and tumor tissues exhibited lower transcript levels of stemness markers, including CCR7, SELL, and TCF7, compared to circulating CD8+ T cells (Fig. 3a-b), resulting in lower stemness signature scores (Fig. 3c). This evidence concerns the gene SELL and neoplasm.